Post-transplantation cyclophosphamide (Cy) as a single agent for GVHD prophylaxis after HLA matched related and unrelated bone marrow transplantation

被引：0
|
作者：
Luznik, L [1 ]
Chen, A [1 ]
Fuchs, EJ [1 ]
Phelps, M [1 ]
Crawford, A [1 ]
Brodsky, RA [1 ]
Huff, CA [1 ]
Jones, RJ [1 ]
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
    Ulas, Turgay
    Namdaroglu, Sinem
    Hindilerden, Ipek Yonal
    Erkurt, Mehmet Ali
    Erer, Kerim
    Yigenoglu, Tugce Nur
    Tiryaki, Tarik Onur
    Hidayet, Emine
    Korkmaz, Serdal
    Ulu, Bahar Uncu
    Yilmaz, Seda
    Kaya, Emin
    Pepeler, Mehmet Sezgin
    Basturk, Abdulkadir
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2025, 64 (01)
  • [42] Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification
    Li, Yun
    Wang, Na
    Zhang, Xiaoying
    Cao, Yang
    Zhang, Lingfeng
    Liu, Aiguo
    Zhang, Yicheng
    BLOOD REVIEWS, 2023, 62
  • [43] Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation
    McAdams, Meredith J.
    Hyder, Mustafa
    Dimitrova, Dimana
    Sadler, Jennifer L.
    McKeown, Christi
    Steinberg, Seth M.
    Chai, Amy
    Napier, Scott
    Stokes, Anita
    Sponaugle, Jennifer
    Hughes, Thomas E.
    RiCha, Nu
    Cuellar-Rodriguez, Jennifer
    Walker, Melissa
    Gress, Ronald E.
    Kanakry, Jennifer A.
    Kanakry, Christopher G.
    BLOOD, 2021, 138
  • [44] Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
    Salibaaw, Rima M.
    Alousia, Amin M.
    Pidala, Joseph
    Arora, Mukta
    Spellman, Stephen R.
    Hemmer, Michael T.
    Wang, Tao
    Abboudg, Camille
    Ahmed, Sairah
    Antin, Joseph H.
    Beitinjanehi, Amer
    Buchbinder, David K.
    Byrne, Michael
    Cahn, Jean-Yves
    Choen, Hannah
    Hanna, Rabi
    HemattiP, Peiman
    Kamble, Rammurti T.
    Kitkor, Carrie L.
    Laughlin, Mary
    Lekakis, Lazaros
    MacMillan, Margaret L.
    Martino, Rodrigo
    Mehta, Parinda A.
    Nishihori, Taiga
    Patel, Sagar S.
    Perales, Miguel-Angel
    Rangarajan, Hemalatha G.
    Ringden, Olov
    Rosenthal, Joseph
    Savani, Bipin N.
    Schultz, Kirk R.
    Seo, Sachiko
    Teshimaag, Takanori
    van der Poela, Marjolein
    Verdonck, Leo F.
    Weisdorf, Daniel
    Wirk, Baldeep
    Yared, Jean A.
    Schriber, Jeffrey
    Champlin, Richard E.
    Ciurea, Stefan O.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 681 - 693
  • [45] Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
    Nakamae, Hirohisa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (04) : 465 - 481
  • [46] Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
    Hirohisa Nakamae
    International Journal of Hematology, 2022, 116 : 465 - 481
  • [47] Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
    Kanakry, Christopher G.
    Perkins, Susan M.
    Daguindau, Etienne
    Vulic, Ante
    Olmsted, Taylor
    Mumaw, Christen
    McCurdy, Shannon R.
    Symons, Heather J.
    Towlerton, Andrea M.
    Warren, Edus H.
    O'Donnell, Paul V.
    Paczesny, Sophie
    Luznik, Leo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S334 - S335
  • [48] Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Kanakry, Jennifer A.
    Kasamon, Yvette L.
    Bolanos-Meade, Javier
    Borrello, Ivan M.
    Brodsky, Robert A.
    Fuchs, Ephraim J.
    Ghosh, Nilanjan
    Gladstone, Douglas E.
    Gocke, Christopher D.
    Huff, Carol Ann
    Kanakry, Christopher G.
    Luznik, Leo
    Matsui, William
    Mogri, Huzefa J.
    Swinnen, Lode J.
    Symons, Heather J.
    Jones, Richard J.
    Anibinder, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1514 - 1517
  • [49] Comparison of outcomes after HLA-haploidentical related versus unrelated hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for acute leukemia
    Gopcsa, Laszlo
    Andrikovics, Hajnalka
    Barta, Aniko
    Batai, Arpad
    Csacsovszki, Otto
    Csukly, Zoltan
    Dolgos, Janos
    Fabian, Janos
    Farkas, Zita
    Fodor, Aniko
    Hardi, Apor
    Kiraly, Agnes
    Lakatos, Gergely
    Lehoczki, Eniko
    Lengyel, Lilla
    Lovas, Nora
    Matrai, Zoltan
    Mikala, Gabor
    Meggyesi, Nora
    Paksi, Melinda
    Peto, Monika
    Rajczy, Katalin
    Reti, Marienn
    Sari, Eszter
    Sinko, Janos
    Sipos, Andrea
    Szilvasi, Aniko
    Torbagyi, Eva
    Valyi-Nagy, Istvan
    Masszi, Tamas
    Remenyi, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 : 158 - 159
  • [50] A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
    Mayumi, Hisanori
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345